Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

1-19 of 19 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

Fibrinogen is not elevated in the cerebrospinal fluid of patients with multiple sclerosis.
Ehling R, Pauli FD, Lackner P, Kuenz B, Santner W, Lutterotti A, Gneiss C, Hegen H, Schocke M, Deisenhammer F, Berger T, Reindl M
Fluids Barriers CNS, 8(1):25, 26 Oct 2011
Cited by: 10 articles | PMID: 22029888 | PMCID: PMC3214845
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Persistency of neutralizing antibodies depends on titer and interferon-beta preparation.
Hegen H, Schleiser M, Gneiss C, Di Pauli F, Ehling R, Kuenz B, Lutterotti A, Berger T, Deisenhammer F
Mult Scler, 18(5):610-615, 19 Oct 2011
Cited by: 26 articles | PMID: 22013146
Add to export list
Olfactory threshold is impaired in early, active multiple sclerosis.
Lutterotti A, Vedovello M, Reindl M, Ehling R, DiPauli F, Kuenz B, Gneiss C, Deisenhammer F, Berger T
Mult Scler, 17(8):964-969, 03 Mar 2011
Cited by: 40 articles | PMID: 21372115
Add to export list
Natalizumab treatment reduces endothelial activity in MS patients.
Millonig A, Hegen H, Di Pauli F, Ehling R, Gneiss C, Hoelzl M, Künz B, Lutterotti A, Rudzki D, Berger T, Reindl M, Deisenhammer F
J Neuroimmunol, 227(1-2):190-194, 23 Aug 2010
Cited by: 24 articles | PMID: 20739072
Add to export list
Influence of interferon-beta therapy switching on neutralizing antibody titres: results from the Austrian Switch Study.
Gneiss C, Koudouovoh-Tripp PM, Ropele S, Gotwald T, Ehling R, Lutterotti A, Aichner F, Ladurner G, Eggers C, Schautzer F, Künz B, Millonig A, Aspeck E, Reindl M, Berger T, Fazekas F, Deisenhammer F
Mult Scler, 15(12):1481-1488, 13 Nov 2009
Cited by: 11 articles | PMID: 19965519
Add to export list
High-dose intravenous interferon beta in patients with neutralizing antibodies (HINABS): a pilot study.
Millonig A, Rudzki D, Hölzl M, Ehling R, Gneiss C, Künz B, Berger T, Reindl M, Deisenhammer F
Mult Scler, 15(8):977-983, 22 May 2009
Cited by: 12 articles | PMID: 19465447
Add to export list
Features of intrathecal immunoglobulins in patients with multiple sclerosis.
Di Pauli F, Gredler V, Kuenz B, Lutterotti A, Ehling R, Gneiss C, Schocke M, Deisenhammer F, Reindl M, Berger T
J Neurol Sci, 288(1-2):147-150, 13 Oct 2009
Cited by: 11 articles | PMID: 19828154
Add to export list
Cerebrospinal fluid B cells correlate with early brain inflammation in multiple sclerosis.
Kuenz B, Lutterotti A, Ehling R, Gneiss C, Haemmerle M, Rainer C, Deisenhammer F, Schocke M, Berger T, Reindl M
PLoS One, 3(7):e2559, 02 Jul 2008
Cited by: 68 articles | PMID: 18596942 | PMCID: PMC2438478
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Comparative study of four different assays for the detection of binding antibodies against interferon-beta.
Gneiss C, Brugger M, Millonig A, Fogdell-Hahn A, Rudzki D, Hillert J, Berger T, Reindl M, Deisenhammer F
Mult Scler, 14(6):830-836, 05 Jun 2008
Cited by: 11 articles | PMID: 18535018
Add to export list
Smoking is a risk factor for early conversion to clinically definite multiple sclerosis.
Di Pauli F, Reindl M, Ehling R, Schautzer F, Gneiss C, Lutterotti A, O'Reilly E, Munger K, Deisenhammer F, Ascherio A, Berger T
Mult Scler, 14(8):1026-1030, 16 Jul 2008
Cited by: 63 articles | PMID: 18632775
Add to export list
MxA protein--an interferon beta biomarker in primary progressive multiple sclerosis patients.
Millonig A, Dressel A, Bahner D, Bitsch A, Bogumil T, Elitok E, Kitze B, Tumani H, Weber F, Gneiss C, Deisenhammer F
Eur J Neurol, 15(8):822-826, 28 Jun 2008
Cited by: 4 articles | PMID: 18549400
Add to export list
Differing immunogenic potentials of interferon beta preparations in multiple sclerosis patients.
Gneiss C, Tripp P, Reichartseder F, Egg R, Ehling R, Lutterotti A, Khalil M, Kuenz B, Mayringer I, Reindl M, Berger T, Deisenhammer F
Mult Scler, 12(6):731-737, 01 Dec 2006
Cited by: 34 articles | PMID: 17263000
Add to export list
Increased serum levels of soluble CD14 indicate stable multiple sclerosis.
Lutterotti A, Kuenz B, Gredler V, Khalil M, Ehling R, Gneiss C, Egg R, Deisenhammer F, Berger T, Reindl M
J Neuroimmunol, 181(1-2):145-149, 13 Oct 2006
Cited by: 11 articles | PMID: 17046070
Add to export list
Plasma levels of soluble adhesion molecules sPECAM-1, sP-selectin and sE-selectin are associated with relapsing-remitting disease course of multiple sclerosis.
Kuenz B, Lutterotti A, Khalil M, Ehling R, Gneiss C, Deisenhammer F, Reindl M, Berger T
J Neuroimmunol, 167(1-2):143-149, 01 Oct 2005
Cited by: 36 articles | PMID: 16040131
Add to export list
Epitope specificity of serum antibodies directed against the extracellular domain of myelin oligodendrocyte glycoprotein: Influence of relapses and immunomodulatory treatments.
Khalil M, Reindl M, Lutterotti A, Kuenz B, Ehling R, Gneiss C, Lackner P, Deisenhammer F, Berger T
J Neuroimmunol, 174(1-2):147-156, 06 Mar 2006
Cited by: 21 articles | PMID: 16516980
Add to export list
Interferon-beta antibodies have a higher affinity in patients with neutralizing antibodies compared to patients with non-neutralizing antibodies.
Gneiss C, Tripp P, Ehling R, Khalil M, Lutterotti A, Egg R, Mayringer I, Künz B, Berger T, Reindl M, Deisenhammer F
J Neuroimmunol, 174(1-2):174-179, 23 Mar 2006
Cited by: 17 articles | PMID: 16556466
Add to export list
Epitope specificity of neutralizing antibodies against IFN-beta.
Gneiss C, Reindl M, Berger T, Lutterotti A, Ehling R, Egg R, Deisenhammer F
J Interferon Cytokine Res, 24(5):283-290, 01 May 2004
Cited by: 18 articles | PMID: 15153311
Add to export list
Increased frequencies of serum antibodies to neurofilament light in patients with primary chronic progressive multiple sclerosis.
Ehling R, Lutterotti A, Wanschitz J, Khalil M, Gneiss C, Deisenhammer F, Reindl M, Berger T
Mult Scler, 10(6):601-606, 01 Dec 2004
Cited by: 33 articles | PMID: 15584481
Add to export list
Interferon-beta: the neutralizing antibody (NAb) titre predicts reversion to NAb negativity.
Gneiss C, Reindl M, Lutterotti A, Ehling R, Egg R, Khalil M, Berger T, Deisenhammer F
Mult Scler, 10(5):507-510, 01 Oct 2004
Cited by: 36 articles | PMID: 15471365
Add to export list

1-19 of 19 results

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

Partnerships & funding